With a market cap of $10 billion, Revvity, Inc. (RVTY) is a global provider of health sciences solutions, technologies, and services. The company delivers a broad portfolio that includes instruments, reagents, informatics, software, imaging technologies, DNA sequencing services, and diagnostic platforms for genetic and infectious disease testing. Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Revvity fits this criterion perfectly. Serving pharmaceutical and bio ...